Here's Our Monthly Update on All 31 Portfolio Stocks, Including 3 on the Buy List
The CNBC Investing Club’s April meeting reviewed all 31 stocks in Jim Cramer’s portfolio, noting a market rebound after the S&P 500 hit a record high. Cramer and Jeff Marks highlighted three new buy recommendations while reassessing positions across tech, industrials, and consumer names. They warned that Nike could be sold if its next quarter disappoints, but kept core bets on Apple, Amazon and Nvidia for AI‑driven upside. The discussion also emphasized inflation‑resilient retailers like Costco and TJX, and highlighted growth themes in gas‑turbine power, data‑center cooling and AI‑related services.
A Mom and Tech Entrepreneur Building AI Advocate for Rare-Disease Families Like Hers
Citizen Health, founded by tech entrepreneurs Farid Vij and Nasha Fitter, has launched an AI‑powered "AI advocate" to help rare‑disease families manage appointments, insurance appeals, and clinical‑trial connections. The platform, backed by $44 million in venture capital—including a $30 million Series A—now supports...
CNBC Cures: A Father and a Doctor on How Raising a Child with Angelman Syndrome Changed Him
Dr. Joseph D’Orazio, an emergency physician, recounts how his son Gabe’s 2018 Angelman syndrome diagnosis transformed his family’s daily life and his own practice. The rare genetic disorder forced the family to restructure work schedules, manage relentless sleep disruption, and...
Stocks Soar on Hopes of Iran War Resolution — Plus, Lilly Takes a Big Swing in Sleep Disorders
U.S. equities surged as the S&P 500 jumped more than 2% on emerging signs that Iran may be moving toward a cease‑fire, buoyed by unconfirmed diplomatic overtures and a Trump statement supporting de‑escalation. Oil prices eased modestly, with WTI crude slipping...
How CNBC Cures Is Bringing Rare Disease Stories to a National Audience
CNBC Cures, launched on Jan 8, 2026 by "Squawk Box" co‑host Becky Quick, is the network’s dedicated platform for rare‑disease awareness. Within two months it has produced a weekly newsletter, a podcast series, a live summit, and a prime‑time documentary titled “CNBC...
Why Novo Nordisk's Ireland Expansion Is Key to Fighting Off Eli Lilly
Novo Nordisk announced a €432 million ($506 million) investment to expand its Athlone, Ireland facility, increasing capacity for oral products such as the newly launched Wegovy pill. The expansion is intended to secure supply outside the United States and help the company...
FDA Chief Warns U.S. Is Losing Ground to China in Early Drug Development, Calls for Faster Trial Approvals
FDA Commissioner Marty Makary warned that the United States is falling behind China in early‑stage drug development, citing slower Phase 1 trial volumes and cumbersome regulatory steps. He identified three primary bottlenecks—hospital contracting, ethical review processes, and the IND application workflow—that...
French Prosecutors Are Investigating Companies Like Nestle and Danone over Contaminated Baby Formula. Here's the Latest
French prosecutors have launched investigations into five companies, including Nestlé and Danone, over allegations of contaminated baby formula. The probe follows reports of bacterial presence in products sold across Europe, prompting health warnings and product recalls. Authorities are examining supply...
How the Largest Health-Care Education Company in U.S. Is Addressing a Growing Jobs Gap
Covista, the former Adtalem Global Education, has rebranded to signal its exclusive focus on health‑care education amid a widening U.S. workforce gap. The company reports more than 24,000 health‑care graduates each year, accounting for roughly 10% of the nation’s nurses...
Novo Nordisk CEO Sees 15 Million Patient Opportunity in Medicare Coverage for Obesity Drugs
Novo Nordisk CEO Mike Doustdar said the firm aims to capture roughly 15 million new patients once Medicare begins covering obesity drugs later this year. The coverage, part of a "most‑favored‑nation" pricing deal with the Trump administration, could expand the market...
Florida Law Models What Genetic Disease Testing Could Be
Florida enacted the Sunshine Genetics Act, creating the nation’s first state‑backed newborn whole‑genome sequencing program. The five‑year pilot will offer free opt‑in testing to 100,000 infants, funded by a mix of private and state resources, and establishes a new Institute...